ConductScience.org, home

Paper39559293

Glycolysis regulated exosomal LINC01214 inhibited CD8+ T cell function and induced anti-PD1 resistance in melanoma via modulating miR-4492/PPP1R11 axis.

Ding Z and 5 others. Noncoding RNA Res, 2025. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Glycolysis regulated exosomal LINC01214 inhibited CD8+ T cell function and induced anti-PD1 resistance in melanoma via modulating miR-4492/PPP1R11 axis. Papers, record 39559293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39559293

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Glycolysis regulated exosomal LINC01214 inhibited CD8+ T cell function and induced anti-PD1 resistance in melanoma via modulating miR-4492/PPP1R11 axis.
PubMed
Journal
Noncoding RNA Res
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
1.67, provisional
iCite
Revised in PubMed
2024-11-20
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ding ZZhi
2Wu BBaojin
3Yang JJunyi
4Wang DDaohe
5Qiao JJing
6Guo FFanli

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127125352From melanocytes to melanomas.Nat Rev Cancer2016https://conductscience.org/library/papers/27125352PubMed
234791419lncRNAfunc: a knowledgebase of lncRNA function in human cancer.Nucleic Acids Res2022https://conductscience.org/library/papers/34791419PubMed
330882958Phosphatase inhibitor PPP1R11 modulates resistance of human T cells toward Treg-mediated suppression of cytokine expression.J Leukoc Biol2019https://conductscience.org/library/papers/30882958PubMed
435129375Treatment patterns and outcomes following disease progression on anti-PD-1 therapies for advanced melanoma.Future Oncol2022https://conductscience.org/library/papers/35129375PubMed
533464299LNCcation: lncRNA localization and function.J Cell Biol2021https://conductscience.org/library/papers/33464299PubMed
634145432Noncoding RNA therapeutics - challenges and potential solutions.Nat Rev Drug Discov2021https://conductscience.org/library/papers/34145432PubMed
726358722ceRNA in cancer: possible functions and clinical implications.J Med Genet2015https://conductscience.org/library/papers/26358722PubMed
832029601The biology, function, and biomedical applications of exosomes.Science2020https://conductscience.org/library/papers/32029601PubMed
929290805Exosome Theranostics: Biology and Translational Medicine.Theranostics2018https://conductscience.org/library/papers/29290805PubMed
1028475890Metabolic Instruction of Immunity.Cell2017https://conductscience.org/library/papers/28475890PubMed
1125724326Exosome and exosomal microRNA: trafficking, sorting, and function.Genomics Proteomics Bioinformatics2015https://conductscience.org/library/papers/25724326PubMed
1232429485Current Molecular Markers of Melanoma and Treatment Targets.Int J Mol Sci2020https://conductscience.org/library/papers/32429485PubMed
1334406447Significance of lncRNA abundance to function.Mamm Genome2022https://conductscience.org/library/papers/34406447PubMed
1424566916Regulation of immune responses by extracellular vesicles.Nat Rev Immunol2014https://conductscience.org/library/papers/24566916PubMed
1533588426CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours.Nature2021https://conductscience.org/library/papers/33588426PubMed
1627805901RING finger E3 ligase PPP1R11 regulates TLR2 signaling and innate immunity.Elife2016https://conductscience.org/library/papers/27805901PubMed
1732759948Exosomes: key players in cancer and potential therapeutic strategy.Signal Transduct Target Ther2020https://conductscience.org/library/papers/32759948PubMed
1830089911Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response.Nature2018https://conductscience.org/library/papers/30089911PubMed
1913679896Molecular biology: microRNA is here to stay.Nature2003https://conductscience.org/library/papers/13679896PubMed
2034509219Immune checkpoint inhibitors in melanoma.Lancet2021https://conductscience.org/library/papers/34509219PubMed

See all 34 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
42500571Epigenetic Modulators and Immunotherapy in Malignant Melanoma.Oncol Res2026https://conductscience.org/library/papers/42500571PubMed
42491964lncRNA HOTAIR in Cancer: Recent Advances and Critical Perspectives on Molecular Mechanisms.Cancer Manag Res2026https://conductscience.org/library/papers/42491964PubMed
42108449From guardians to traitors: molecular mechanisms of tumor-induced T cell betrayal.Mol Cancer2026https://conductscience.org/library/papers/42108449PubMed
41992768Novel insights into extracellular vesicles: An update on biomolecules, immunomodulation and clinical strategies in skin melanoma.Clin Transl Med2026https://conductscience.org/library/papers/41992768PubMed
41737608Long non-coding RNAs in the exosomal network: dual roles and clinical implications in cancer.Anim Cells Syst (Seoul)2026https://conductscience.org/library/papers/41737608PubMed
41550841Mechanistic roles of long non-coding RNAs in gastric cancer therapy resistance.Noncoding RNA Res2026https://conductscience.org/library/papers/41550841PubMed
40678154Dual role of lncRNA OTUD6B-AS1 in immune evasion and ferroptosis resistance: A prognostic and therapeutic biomarker in breast cancer.Noncoding RNA Res2025https://conductscience.org/library/papers/40678154PubMed
40282449Novel Biological Strategies for Melanoma Therapy: A Focus on lncRNAs and Their Targeting.Cancers (Basel)2025https://conductscience.org/library/papers/40282449PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
GZMB3002PubTator's text mininghttps://conductscience.org/library/genes/3002NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
LINC01214101928022PubTator's text mininghttps://conductscience.org/library/genes/101928022NCBI Gene
MIR4492100616376PubTator's text mininghttps://conductscience.org/library/genes/100616376NCBI Gene
PPP1R116992PubTator's text mininghttps://conductscience.org/library/genes/6992NCBI Gene
SPATA29825PubTator's text mininghttps://conductscience.org/library/genes/9825NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39559293

GET https://conductscience.org/api/papers/v1/39559293/references?page=2